7 completed, 3 unknown, 1 not yet recruiting, 1 terminated. 13 Phase 2, 4 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 7, Unknown 3, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 4 | Completed 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow cetrorelix: new trials by email Literature Review of cetrorelix trials Research Report on cetrorelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI Drospirenone drug, Cetrorelix 0.25 mg - Poor Ovarian Reserve, Infertility (IVF Patients) | Phase 1 / Phase 2 | Not yet recruiting | Ahmed Saad | 100 | 2026-08-01 | 2026-07-30 |
| Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?! Cetrorelix drug, Drospirenone drug - PCOS (Polycystic Ovary Syndrome) | Phase 1 / Phase 2 | Completed | Ahmed Saad | 50 | 2024-10-01 | 2025-01-22 |
| Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI Dydrogesterone Tablets, Cetrorelix - IVF, PCO | Phase 2 / Phase 3 | Completed | Beni-Suef University | 200 | 2024-01-01 | 2026-04-15 |
| Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures BG2109, Cetrorelix - Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation | Phase 2 | Unknown | Bio Genuine (Shanghai) Biotech Co., Ltd. | 240 | 2023-08-01 | 2023-07-27 |
| Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Human Chorionic Gonadotropin (hCG), Gonadotropins, GNRH-A Triptorelin - Female Infertility, Female Infertility Due to Ovulatory Disorder | Phase 1 / Phase 2 | Completed | Lebanese University | 200 | 2018-02-01 | 2023-05-09 |
| Antagonist Protocol in IVF Gonadotropins releasing hormone antagonist - Infertility | Phase 2 | Unknown | Woman's Health University Hospital, Egypt | 200 | 2015-01-01 | 2016-02-15 |
| Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome Cetrorelix - Infertility | Phase 2 / Phase 3 | Unknown | Benha University | 48 | 2014-10-01 | 2017-03-30 |
| Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome Cetrorelix - Assisted Reproduction | Phase 2 | Completed | Ain Shams University | 84 | 2014-06-01 | 2016-05-27 |
| Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis Cetrorelix, Placebo - Rheumatoid Arthritis | Phase 2 | Completed | Betanien Hospital | 104 | 2008-05-01 | 2012-08-06 |
| A Phase II Study to Assess the Efficacy and Safety of LuverisĀ® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age r-hLH + r-hFSH, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG) - Infertility, Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 93 | 2007-11-01 | 2014-02-27 |
| Lutropin Alfa in Women at Risk of Poor Response r-FSH, r-hLH, Analogous GnRH antagonist - Ovarian Stimulation | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 58 | 2005-12-07 | 2018-08-28 |
| A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis Cetrorelix - Endometriosis | Phase 2 | Completed | Solvay Pharmaceuticals | 2005-11-01 | 2008-03-31 | |
| Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) Cetrotide - Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) | Phase 1 / Phase 2 | Withdrawn | Wolfson Medical Center | 2016-03-30 |
Infertility (5) · Endometriosis (2) · Helping Behavior (2) · Polycystic Ovary Syndrome (2) · Arthritis, Rheumatoid (1) · Endometritis (1) · Infertility, Female (1) · Leiomyoma (1) · Pregnancy, Ectopic (1) · Primary Ovarian Insufficiency (1) · Salpingitis (1) · Uterine Anomalies (1)
Ahmed Saad (2) · Merck KGaA, Darmstadt, Germany (2) · Ain Shams University (1) · Benha University (1) · Beni-Suef University (1) · Betanien Hospital (1) · Bio Genuine (Shanghai) Biotech Co., Ltd. (1) · Lebanese University (1) · Solvay Pharmaceuticals (1) · Wolfson Medical Center (1) · Woman's Health University Hospital, Egypt (1)
Egypt (5) · Spain (2) · Australia (1) · Belgium (1) · Bulgaria (1) · China (1) · Germany (1) · Lebanon (1) · Norway (1) · Romania (1) · Russia (1) · South Africa (1) · Ukraine (1)
Dina M Dakhly, MD (1) · Nehman Makdissy, Professor (1) · Samar El Hamoui, Dr (1) · Xiaoyan Liang (1)
2004 (1), 2005 (1)